Expression of Concern: miR-145 sensitizes ovarian cancer cells to paclitaxel by targeting Sp1 and Cdk6

Int J Cancer. 2024 Jul 31. doi: 10.1002/ijc.35121. Online ahead of print.
No abstract available

Publication types

  • Expression of Concern